DEA Head Refrains from Cannabis Rescheduling Comment Amid Ongoing Process

The head of the Drug Enforcement Administration (DEA), Anne Milgram, appeared before lawmakers to discuss the agency’s recent determination on marijuana rescheduling but refrained from commenting on the ongoing administrative process.

Smart Approaches to Marijuana Raises Questions

Smart Approaches to Marijuana (SAM) raised questions about whether Milgram personally signed the proposed rescheduling rule, but the administrator declined to address the issue directly.

Milgram’s Testimony

Milgram focused primarily on combating international fentanyl trafficking but briefly addressed the marijuana rescheduling news, stating that it would be inappropriate for her to comment on the ongoing process.

Status of Rescheduling Proposal

DOJ is seeking to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act, but several steps remain before a rule is finalized and implemented.

Lawmaker Inquiries

Lawmakers questioned Milgram about various aspects of the rescheduling decision, but she consistently declined to comment, citing the ongoing regulatory process.

Former DEA Administrator’s Perspective

Former DEA Administrator Asa Hutchinson weighed in on the rescheduling proposal, calling it understandable and reflective of public sentiment toward the medical value of cannabis.

Political Reactions

While some Democrats see the rescheduling as a positive step, a Republican senator criticized efforts to legalize marijuana, arguing that it would stimulate more crime.

Milgram’s testimony underscores the complexity and sensitivity surrounding the DEA’s marijuana rescheduling decision, highlighting the need for careful consideration and adherence to regulatory processes.